Learning human biology: a Q&A with Genentech’s Nikhil Wagle

The growing ability to learn from patient samples begets the responsibility to do so, according to Genentech’s SVP and Global Head of Translational Medicine Nikhil Wagle.

Having joined the Genentech Inc. unit of  Roche (SIX:ROG; OTCQB:RHHBY) from Broad Institute of MIT and Harvard in February of last year, Wagle runs the company’s two-year-old Translational Medicine department, which is responsible for the discovery, development and use of biomarkers across its entire pipeline...